Femara 2.5 mg contains letrozole, a non-steroidal aromatase inhibitor used as an antineoplastic agent. Each package contains 30 film-coated tablets manufactured by Novartis Pharma Stein AG. The tablets are designed for prescribed medical use. This is a prescription medication that comes in film-coated tablet form. The active ingredient letrozole is dosed at 2.5 mg per tablet. The product is manufactured in Switzerland by Novartis Pharma Stein AG and imported by Novartis Healthcare Philippines Inc. The package contains 30 tablets.